TWiV 635 Mask hysteria
This Week in Virology Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Brianne […]
TWiV 635 Mask hysteria Read More »
This Week in Virology Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Brianne […]
TWiV 635 Mask hysteria Read More »
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 25 July 2020 Vincent
TWiV 645 Lions and tigers and zookeepers (oh my) Read More »
This Week in Virology Host: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Brianne
TWiV 642: Bringin’ in 50 keys of spike mRNA Read More »
This Week in Virology Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Rich Condit Guests:
TWiV 638 Do, there is no try Read More »
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 18 June 2022 Vincent
TWiV 910 COVID-19 Update #119 Read More »
Outcomes of SARS-CoV-2 Reinfection | Children and COVID-19: State level Data Report | CDC Recommends COVID-19 Vaccines for Young Children | Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis | Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters | Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons | Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022
This Week in Virology Host: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Brianne
TWiV 648 Life is for learning Read More »
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 09 August 2020 Vincent
TWiV 651 FDA rules with Denise Esposito Read More »
Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial | Persistence of residual SARS-CoV-2 viral antigen and RNA in tissues of patients with long COVID-19 | Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 | Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons | The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 16 August 2020 Vincent
TWiV 654 TWiVering with Excitement Read More »
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.